Tomas Bubinas
Direttore/Membro del Consiglio presso AB INVL BALTIC FARMLAND
Profilo
Tomas Bubinas is currently an Independent Director at Invalda INVL AB, an Independent Director at INVL Baltic Farmland AB, and a Member of the Association of Chartered Accountants In England & Wales.
Previously, he worked as a Finance Director at Teva Baltics UAB, Chief Financial Officer at Teva Biopharmaceuticals USA, Inc., Senior Manager at PricewaterhouseCoopers UAB, and Senior Auditor at Cooper & Lybrand, Inc. He also served as the Chief Operating Officer at Biotechpharma UAB from 2013 to 2022.
Mr. Bubinas holds a graduate degree from Vilnius University and an MBA from the Baltic Management Institute.
Posizioni attive di Tomas Bubinas
| Società | Posizione | Inizio |
|---|---|---|
| AB INVL BALTIC FARMLAND | Direttore/Membro del Consiglio | 27/04/2022 |
| INVALDA INVL, AB | Direttore/Membro del Consiglio | 01/01/2022 |
| Association of Chartered Accountants In England & Wales | Corporate Officer/Principal | - |
Precedenti posizioni note di Tomas Bubinas
| Società | Posizione | Fine |
|---|---|---|
Biotechpharma UAB
 Biotechpharma UAB Pharmaceuticals: MajorHealth Technology Biotechpharma UAB operates as a contract development and manufacturing organization for biopharmaceuticals. | Direttore operativo | 01/01/2022 |
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Direttore Finanziario/CFO | 02/01/2012 |
| Cooper & Lybrand, Inc. | Comptroller/Controller/Auditor | - |
PricewaterhouseCoopers UAB
 PricewaterhouseCoopers UAB Miscellaneous Commercial ServicesCommercial Services Part of Stichting Pricewaterhousecoopers EE, PricewaterhouseCoopers UAB is a company based in Vilnius, Lithuania. | Corporate Officer/Principal | - |
Teva Baltics UAB
 Teva Baltics UAB Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Teva Baltics UAB is a Lithuanian company that develops and manufactures recombinant protein products. The company is based in Vilnius, Lithuania. The company was founded in 1999. Teva Baltics was acquired by SICOR, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., from Rakepoll Finance NV on July 25, 2001 for $36.49 million. | Direttore Finanziario/CFO | - |
Formazione di Tomas Bubinas
| Vilnius University | Graduate Degree |
| Baltic Management Institute | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AB INVL BALTIC FARMLAND | Finance |
| INVALDA INVL, AB | Finance |
| Aziende private | 6 |
|---|---|
| Association of Chartered Accountants In England & Wales | |
Biotechpharma UAB
Biotechpharma UAB Pharmaceuticals: MajorHealth Technology Biotechpharma UAB operates as a contract development and manufacturing organization for biopharmaceuticals. | Health Technology |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Health Technology |
Teva Baltics UAB
Teva Baltics UAB Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Teva Baltics UAB is a Lithuanian company that develops and manufactures recombinant protein products. The company is based in Vilnius, Lithuania. The company was founded in 1999. Teva Baltics was acquired by SICOR, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., from Rakepoll Finance NV on July 25, 2001 for $36.49 million. | Health Technology |
PricewaterhouseCoopers UAB
PricewaterhouseCoopers UAB Miscellaneous Commercial ServicesCommercial Services Part of Stichting Pricewaterhousecoopers EE, PricewaterhouseCoopers UAB is a company based in Vilnius, Lithuania. | Commercial Services |
| Cooper & Lybrand, Inc. |
- Borsa valori
- Insiders
- Tomas Bubinas
